Vera Therapeutics, Inc. — Director's Dealing 2021

May 18, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vera Therapeutics, Inc. (VERA)
CIK: 0001831828
Period of Report: 2021-05-13

Reporting Person: SEIDENBERG BETH C (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-13	Stock Option (right to buy)	$11.00	A	9925	Acquired	2031-05-12	Class A Common Stock (9925)	Direct

Footnotes

F1: The shares subject to the option will vest on the earlier of May 13, 2022 or the 2022 annual meeting of stockholders.